The HA-conjugated N-GQDs (HA-N-GQDs) are designed to bind alongside CD44, that is over-expressed on the surface of MCF-7 breast cancer cells, leading to enhanced fluorescence in these cells. Here, CD44 is linked to breast carcinoma.